CurtisRChongMD

Oncology • Palo Alto, CA

Clinical Fellow in Medicine, Dana-Farber Cancer Institute

Join to view full profile

Dr. Chong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chong's full profile

Already have an account?

Office
300 Pasteur Dr
Palo Alto, CA 94304
Phone+1 650-723-4000

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
Massachusetts General HospitalResidency, Internal Medicine, 2008 - 2011
Johns Hopkins University School of MedicineClass of 2008

Certifications & Licensure

MA State Medical License 2010 - 2026
CA State Medical License 2016 - 2025
NY State Medical License 2016 - 2020
NJ State Medical License 2017 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

1 citations
Resolution of metastatic neck nodes associated with a periauricular cutaneous squamous cell carcinoma after intranodal injection of talimogene laherparepvec.
Yonglu Che, Curtis Chong, Marketa Limova, Laura Morris, Sunil Arani Reddy
JAAD Case Reports. 2024-04-01
Reply to Groeneveld et al.
Curtis R Chong, Bevin Cohen, Mini Kamboj
Clinical Infectious Diseases. 2020-03-17
74 citations
Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors.
Curtis Robert Chong, Vivian Park, Bevin Cohen, Michael A. Postow, Jedd D. Wolchok
Clinical Infectious Diseases. 2020-01-02

Lectures

A phase Ia/Ib, open label, multicenter, dose-escalation study of BI 907828 (MDM2-p53 antagonist) in adult patients with advanced or metastatic solid tumors.
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

مضادات الفيروسات التي لم تكن يوما كذلك: نتائج مضللة كانت نِتاج إعادة توجيه أدوية مُرخصة لمعالجة الكوفيد 19July 11th, 2021